FDA clears AngioScore catheter

05/2/2008 | American City Business Journals

The FDA has granted AngioScore approval to market its AngioSculpt PTA catheter, which can be used for balloon dilatation of lesions in various arteries and to treat certain obstructive lesions. The clearance allows the company "to address several of the largest and fastest growing segments of the peripheral artery disease market in the U.S.," CEO Thomas R. Trotter said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC